Tissue-specific selection of optimal reference genes for expression analysis of anti-cancer drug-related genes in tumor samples using quantitative real-time RT-PCR

Experimental and Molecular Pathology

Volumn 98, Issue 3, 2015, Pages 375-381

  Wang, Huijuan ^a,b   Yang, Bobo ^a   Geng, Tingting ^b   Li, Bin ^a,b   Dai, Penggao ^a,b   Chen, Chao ^a,b  

^a NORTHWEST UNIVERSITY   (China)

^b National Engineering Research Center for Miniaturized Detection System   (China)

Author keywords

Anticancer drug related gene; Quantitative real time PCR (qRT PCR); Reference gene; Tumor tissue

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; CHEMOKINE RECEPTOR CXCR6; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; VASCULOTROPIN RECEPTOR 2; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN;

ACTB GENE; ARTICLE; BREAST TUMOR; CANCER CLASSIFICATION; CANCER TISSUE; COLON TUMOR; COMPUTER PROGRAM; CONTROLLED STUDY; EGFR GENE; ERCC1 GENE; ESOPHAGUS TUMOR; GAPDH GENE; GENE; GENE EXPRESSION PROFILING; GENETIC STABILITY; GUSB GENE; HER2 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG TUMOR; NEOPLASM; PRINCIPAL COMPONENT ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECTUM TUMOR; REFERENCE GENE; RELIABILITY; RPLPO GENE; RRM1 GENE; STMN1 GENE; STOMACH TUMOR; TFRC GENE; TISSUE SPECIFICITY; TOP2A GENE; TRANSCRIPTION REGULATION; TUBB3 GENE; TUMOR SUPPRESSOR GENE; TYMS GENE; VEGFR2 GENE; ANTIBODY SPECIFICITY; DRUG EFFECTS; GASTROINTESTINAL TUMOR; GENETICS; HELA CELL LINE; METABOLISM; STANDARD; STANDARDS;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION PROFILING; HELA CELLS; HUMANS; LUNG NEOPLASMS; ONCOGENE PROTEINS; ORGAN SPECIFICITY; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE STANDARDS; TUMOR SUPPRESSOR PROTEINS;

EID: 84926300471     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.10.014     Document Type: Article

References (33)

1. Andersen C.L., et al. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004, 64:5245-5250.
2. Atkins D., et al. Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections. J. Histochem. Cytochem. 2004, 52:893-901.
3. Bamias G., et al. Comparative study of candidate housekeeping genes for quantification of target gene messenger RNA expression by real-time PCR in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 2013, 19:2840-2847.
4. Bepler G., et al. RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer. J. Clin. Oncol. 2006, 24:4731-4737.
5. Bepler G., et al. Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer. J. Clin. Oncol. 2013, 31:2404-2412.
6. Bunn P.A., Franklin W. Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer. Semin. Oncol. 2002, 29:38-44.
7. Ceppi P., et al. ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. Ann. Oncol. 2006, 17:1818-1825.
8. Chen D., et al. Evaluation and identification of reliable reference genes for pharmacogenomics, toxicogenomics, and small RNA expression analysis. J. Cell. Physiol. 2011, 226:2469-2477.
9. Cobo M., et al. Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer. J. Clin. Oncol. 2007, 25:2747-2754.
10. de Kok J.B., et al. Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab. Investig. 2005, 85:154-159.
11. Drury S., et al. Selection of reference genes for normalization of qRT-PCR data derived from FFPE breast tumors. Diagn. Mol. Pathol. 2009, 18:103-107.
12. Fassunke J., et al. qPCR in gastrointestinal stromal tumors: evaluation of reference genes and expression analysis of kit and the alternative receptor tyrosine kinases FLT3, CSF1-R, PDGFRB, MET and AXL. BMC Mol. Biol. 2010, 11:100.
13. Kolkova Z., et al. Normalizing to GADPH jeopardises correct quantification of gene expression in ovarian tumours - IPO8 and RPL4 are reliable reference genes. J. Ovarian Res. 2013, 6:60.
14. Kozera B., Rapacz M. Reference genes in real-time PCR. J. Appl. Genet. 2013, 54:391-406.
15. Lee W., et al. Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development. Oncologist 2005, 10:104-111.
16. Lord R.V., et al. Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Clin. Cancer Res. 2002, 8:2286-2291.
17. Menard S., et al. HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer. Ann. Oncol. 2001, 12(Suppl. 1):S15-S19.
18. Moen E.L., et al. Pharmacogenomics of chemotherapeutic susceptibility and toxicity. Genome Med. 2012, 4:90.
19. Olaussen K.A., et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N. Engl. J. Med. 2006, 355:983-991.
20. Paik S., et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 2004, 351:2817-2826.
21. Palma B.B., et al. Functional characterization of eight human cytochrome P450 1A2 gene variants by recombinant protein expression. Pharmacogenomics J. 2010, 10:478-488.
22. Pfaffl M.W., et al. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol. Lett. 2004, 26:509-515.
23. Radonic A., et al. Guideline to reference gene selection for quantitative real-time PCR. Biochem. Biophys. Res. Commun. 2004, 313:856-862.
24. Romanowski T., et al. Housekeeping genes as a reference in quantitative real-time RT-PCR. Postepy Hig. Med. Dosw. 2007, 61:500-510.
25. Rubie C., et al. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. Mol. Cell. Probes 2005, 19:101-109.
26. Salomon D.S., et al. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol. 1995, 19:183-232.
27. Shirota Y., et al. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. J. Clin. Oncol. 2001, 19:4298-4304.
28. Soes S., et al. Identification of accurate reference genes for RT-qPCR analysis of formalin-fixed paraffin-embedded tissue from primary non-small cell lung cancers and brain and lymph node metastases. Lung Cancer 2013, 81:180-186.
29. Ueda S., et al. Evaluation of ERCC1 expression for cisplatin sensitivity in human hepatocellular carcinoma. Ann. Surg. Oncol. 2011, 18:1204-1211.
30. Vandesompele J., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. (research0034).
31. Watters J.W., McLeod H.L. Cancer pharmacogenomics: current and future applications. Biochim. Biophys. Acta 2003, 1603:99-111.
32. Zeng C., et al. Selection of optimal reference genes for quantitative RT-PCR studies of boar spermatozoa cryopreservation. Cryobiology 2014, 68:113-121.
33. Zhang Y., et al. Selection of reliable reference genes in Caenorhabditis elegans for analysis of nanotoxicity. PLoS One 2012, 7:e31849.